[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=89116]], camposKey:0014-4835 2024-01-01 Analysis of the mucosal chemokines CCL28, CXCL14, and CXCL17 in dry eye disease: An in vitro and clinical investigation00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=81857]], camposKey:1542-0124 2024-01-01 Gene expression changes in conjunctival cells associated with contact lens wear and discomfort3142, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=89248]], camposKey:0927-3948 2024-01-01 Tear Cytokines as Predictive Biomarkers of Success in Contact Lens Discomfort Management23392347, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=89300]], camposKey:0146-0404 2023-01-01 Gene expression changes in conjunctival epithelial cells after long-term management in chronic ocular pain and dry eye patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75394]], camposKey:2077-0383 2022-12-01 Tear and Plasma Levels of Cytokines in Patients with Uveitis: Search for Active Disease Biomarkers00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=72870]], camposKey:2045-2322 2022-10-06 Effect of a single vectored thermal pulsation treatment of Meibomian gland dysfunction patients under controlled environmental conditions00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75140]], camposKey:1542-0124 2022-10-01 Phenotypic characterization of patients developing chronic dry eye and pain after refractive surgery: A cross-sectional study6374, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=72615]], camposKey:1664-3224 2022-07-19 Conjunctival Intraepithelial Lymphocytes, Lacrimal Cytokines and Ocular Commensal Microbiota: Analysis of the Three Main Players in Allergic Conjunctivitis00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=72871]], camposKey:0014-4835 2022-06-01 Inflammation-related molecules in tears of patients with chronic ocular pain and dry eye disease00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75766]], camposKey:2304-8158 2022-02-01 Potential Ophthalmological Application of Extracts Obtained from Tuna Vitreous Humor Using Lactic Acid-Based Deep Eutectic Systems00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75091]], camposKey:1367-0484 2022-01-01 Diurnal variation on tear stability and correlation with tear cytokine concentration1017050, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=89299]], camposKey:0146-0404 2022-01-01 Evaluation of gene expression in conjunctival epithelial cells associated with contact lens wear and discomfort00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75765]], camposKey:2077-0383 2022-01-01 Olive Pomace Phenolic Compounds: From an Agro-Industrial By-Product to a Promising Ocular Surface Protection for Dry Eye Disease00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66298]], camposKey:1542-2321 2021-01-01 Development of a Questionnaire for Detecting Changes in Dry Eye Disease-Related Symptoms814, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66534]], camposKey:2168-0485 2021-01-01 Pressurized Liquid Extraction Optimization from Supercritical Defatted Olive Pomace: A Green and Selective Phenolic Extraction Process55905602, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59335]], camposKey:1542-0124 2020-10-01 Inflammatory status predicts contact lens discomfort under adverse environmental conditions829840, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52801]], camposKey:0014-4835 2020-01-01 Clinical and tear cytokine profiles after advanced surface ablation refractive surgery: A six-month follow-up00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52911]], camposKey:1542-2321 2020-01-01 Development of a Questionnaire for Detecting Changes in Dry Eye Disease-Related Symptoms00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52802]], camposKey:0929-8673 2020-01-01 Tear inflammatory molecules in contact lens wearers: A literature review523548, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56653]], camposKey:0146-0404 2019-07-01 Conjunctival neuropathic and inflammatory pain-related gene expression in contact lens discomfort00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52942]], camposKey:0927-3948 2019-01-01 Conjunctival Neuropathic and Inflammatory Pain-Related Gene Expression with Contact Lens Wear and Discomfort00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53437]], camposKey:1367-0484 2019-01-01 Inflammatory mediators and substance p in tears during contact lens discomfort00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53434]], camposKey:1367-0484 2019-01-01 Is there any difference in the ocular surface between subjects with and without contact lens discomfort?00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56652]], camposKey:0146-0404 2019-01-01 Ocular Surface Pathology in Patients Suffering from Acute Intoxication with Occupational Mercury00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41511]], camposKey:1542-0124 2019-01-01 Response profiles to a controlled adverse desiccating environment based on clinical and tear molecule changes502515, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52943]], camposKey:0927-3948 2019-01-01 Substance P Level in Tears as a Potential Biomarker for Contact Lens Discomfort00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41510]], camposKey:1367-0484 2019-01-01 The ability of the Contact Lens Dry Eye Questionnaire (CLDEQ)-8 to detect ocular surface alterations in contact lens wearers273277, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42955]], camposKey:0927-3948 2019-01-01 Topical Quercetin and Resveratrol Protect the Ocular Surface in Experimental Dry Eye Disease10231032, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11553]], camposKey:0271-3683 2018-01-01 Are Contact Lens Discomfort or Soft Contact Lens Material Properties Associated with Alterations in the Corneal Sub-Basal Nerve Plexus?487492, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53812]], camposKey:1367-0484 2018-01-01 Effect of the environmental conditions on tear inflammatory mediators concentration in contact lens wearers00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=37802]], camposKey:1542-0124 2018-01-01 Severity, therapeutic, and activity tear biomarkers in dry eye disease: An analysis from a phase III clinical trial368376, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3536]], camposKey:1542-0124 2018-01-01 Topical fluorometholone treatment and desiccating stress change inflammatory protein expression in tears8492, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56660]], camposKey:0146-0404 2017-06-01 Tear molecular biomarkers can predict the development of ocular chronic graft versus host disease before hematopoietic stem cell transplantation00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53813]], camposKey:1755-375X 2017-01-01 Corneal confocal microscopy assessment in contact lens discomfort00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41612]], camposKey:1755-375X 2017-01-01 Cytokine and chemokine tear levels in patients with uveitis405414, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3534]], camposKey:0020-8167 2017-01-01 Effects of the external environment on dry eye disease2340, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3529]], camposKey:0146-0404 2017-01-01 Prehematopoietic stem cell transplantation tear cytokines as potential susceptibility biomarkers for ocular chronic graft-versus-host disease48364846, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3533]], camposKey:0161-6420 2017-01-01 Reply02, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11556]], camposKey:0277-3740 2017-01-01 RNA Collection from Human Conjunctival Epithelial Cells Obtained with a New Device for Impression Cytology5963, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53614]], camposKey:0146-0404 2016-09-01 Tear Cytokine Biomarkers in Dry Eye Patients Subjected to Environmental Stress and Treated with Topical 0.1% Fluorometholone00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3543]], camposKey:0146-0404 2016-01-01 Biomarkers in ocular chronic graft versus host disease: Tear cytokine- and chemokine-based predictive model746758, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3541]], camposKey:0002-9394 2016-01-01 Clinical and Molecular Inflammatory Response in Sjögren Syndrome-Associated Dry Eye Patients under Desiccating Stress00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3537]], camposKey:1040-5488 2016-01-01 Corneal sensitivity and inflammatory biomarkers in contact lens discomfort892900, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3538]], camposKey:0277-3740 2016-01-01 Effect of environmental conditions on the concentration of tear inflammatory mediators during contact lens wear11921198, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53773]], camposKey:1878-5077 2016-01-01 Tear fluid biomarkers in ocular and systemic disease: Potential use for predictive, preventive and personalised medicine00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39503]], camposKey:0146-0404 2016-01-01 Tear fluid proteome reveals inflammation and immune response proteins as potential predictive biomarkers of the effects of desiccating stress and dry eye treatments00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3542]], camposKey:0161-6420 2016-01-01 Topical Fluorometholone Protects the Ocular Surface of Dry Eye Patients from Desiccating Stress: A Randomized Controlled Clinical Trial141153, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56663]], camposKey:0146-0404 2015-06-01 Gene expression-based predictive models of Graft versus Host Disease-associated Dry Eye00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56662]], camposKey:0146-0404 2015-06-01 The utility of tear cytokine profiles in the diagnosis of Graft vs Host Disease-Associated Dry Eye00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=8939]], camposKey:1755-375X 2015-01-01 Environmental factors in ocular surface disease00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3547]], camposKey:0146-0404 2015-01-01 Gene expression-based predictive models of graft versus host disease-associated dry eye45704581, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=8944]], camposKey:0271-3683 2015-01-01 In Vitro Model for Predicting the Protective Effect of Ultraviolet-Blocking Contact Lens in Human Corneal Epithelial Cells792799, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3544]], camposKey:0146-0404 2015-01-01 Quercetin and resveratrol decrease the inflammatory and oxidative responses in human ocular surface epithelial cells27092719, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56659]], camposKey:0146-0404 2014-04-01 An in vitro study of anti-inflammatory effect of Quercetin and Resveratrol polyphenols in ocular surface epithelial cells.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56661]], camposKey:0146-0404 2014-04-01 An in vivo study of anti-inflammatory effect of Quercetin and Resveratrol polyphenols in a desiccating stress mouse model of dry eye.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53612]], camposKey:0146-0404 2014-04-01 Corneal sensitivity and inflammatory mediators in tears of asymptomatic and symptomatic hydrogel contact lens wearers00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53613]], camposKey:0146-0404 2014-04-01 Lacrimal Functional Unit Response of Dry Eye Patients to Desiccating Conditions00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56658]], camposKey:0146-0404 2014-04-01 Molecular Biomarkers in Ocular Graft vs Host Disease (GVHD)-Associated Dry Eye (DE)00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=768]], camposKey:0271-3683 2014-01-01 Basal values, intra-day and inter-day variations in tear film osmolarity and tear fluorescein clearance673679, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=788]], camposKey:0002-9394 2014-01-01 Dry Eye Exacerbation in Patients Exposed to Desiccating Stress under Controlled Environmental Conditions788798, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=751]], camposKey:0014-4835 2014-01-01 Intra- and inter-day variation of cytokines and chemokines in tears of healthy subjects4349, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53609]], camposKey:0146-0404 2013-06-01 Simulation of Acute Symptomatic Exacerbation in Dry Eye (DE) Patients After a Two Hour Exposure to Adverse Conditions in an Environmental Chamber00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56657]], camposKey:0146-0404 2013-06-01 Tear Molecule Levels and Conjunctival Inflammatory Gene Expression in Atopic Keratoconjunctivitis (AKC)00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=729]], camposKey:0014-4835 2013-01-01 Effect of TGF-beta on ocular surface epithelial cells88100, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=792]], camposKey:0146-0404 2013-01-01 Influence of a Controlled Environment Simulating an In-Flight Airplane Cabin on Dry Eye Disease20932099, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=780]], camposKey:1528-4050 2012-01-01 Molecular and cellular biomarkers in dry eye disease and ocular allergy523533, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=746]], camposKey:0146-0404 2011-01-01 Activation of MAPK Signaling Pathway and NF-kappa B Activation in Pterygium and Ipsilateral Pterygium-Free Conjunctival Specimens58425852, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38603]], camposKey:0927-3948 2010-06-01 Dry eye disease as an inflammatory disorder190199, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56654]], camposKey:0146-0404 2010-04-01 Activation of MAPK Signaling Pathway and NF-B in Primary Pterygium Specimens Correlate With Clinical Parameters00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56656]], camposKey:0146-0404 2010-04-01 Cytokine and Chemokine Tear Levels in Healthy Subjects; Intra- and Inter-Day Variation Study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56655]], camposKey:0146-0404 2010-04-01 Neuroretinal Reactive Gliosis is Not Appreciable If Macrophage-Like Cells Do Not Produce TNF Alpha and/or IL-1b. Preliminary Results00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=742]], camposKey:1755-375X 2010-01-01 Cytokine and chemokine levels in tears from healthy subjects00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=790]], camposKey:0927-3948 2010-01-01 Dry Eye Disease as an Inflammatory Disorder244253, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=731]], camposKey:1090-0535 2010-01-01 Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease862873, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=777]], camposKey:1043-4666 2008-01-01 Cytokine responses by conjunctival epithelial cells: An in vitro model of ocular inflammation160167, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=666]], camposKey:1744-666X 2008-01-01 Cytokines and chemokines in immune-based ocular surface inflammation457467, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=771]], camposKey:0003-9950 2006-01-01 Altered expression of neurotransmitter receptors and neuromediators in vernal keratoconjunctivitis462468, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=767]], camposKey:0146-0404 2006-01-01 Chitosan nanoparticles as a potential drug delivery system for the ocular surface: Toxicity, uptake mechanism and in vivo tolerance14161425, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=665]], camposKey:1528-4050 2006-01-01 Muscarinic receptors in the ocular surface379382, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=750]], camposKey:0271-3683 2005-01-01 Alpha(2)-Adrenergic receptors are present in normal human conjunctiva11211129, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=754]], camposKey:0146-0404 2005-01-01 Expression of muscarinic and adrenergic receptors in normal human conjunctival epithelium504513, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56649]], camposKey:0146-0404 2005-01-01 Inflammatory cytokine effects on co-stimulatory molecule and chemokine expression in the human conjunctival epithelial cell line, IOBA-NHC00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56650]], camposKey:0146-0404 2005-01-01 Ocular surface in vivo tolerance to new nanoparticulate polymer systems designed for drug delivery00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53750]], camposKey:1286-4579 2005-01-01 Response of rat fasciculata-reticularis cells in primary culture to bacterial lipopolysaccharide10771086, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=712]], camposKey:1528-4050 2005-01-01 The role of the conjunctival epithelium in ocular allergy441445, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39488]], camposKey:1542-0124 2005-01-01 Variation in the expression of inflammatory markers and neuroreceptors in human conjunctival epithelial cells00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56651]], camposKey:0146-0404 2004-04-01 Presence of alpha 2-adrenergic receptor subtypes in the normal human conjunctiva.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=778]], camposKey:0014-4835 2004-01-01 Impression cytology of the ocular surface: a review457472, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56666]], camposKey:0146-0404 2003-05-01 Effect of IFN gamma on muscarinic and adrenergic receptor expression in a normal human conjunctival (NHC) epithelial cell line: Flow cytometry study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56668]], camposKey:0146-0404 2003-05-01 Expression of neurotransmitter receptors and Vip in conjunctival biopsies of vernal keratoconjunctivitis patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56664]], camposKey:0146-0404 2003-05-01 In vitro models of ocular inflammation using normal human conjunctival cells00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56667]], camposKey:0146-0404 2003-05-01 Western blot analysis of muscarinic and adrenergic receptors in a normal human conjunctival (NHC) epithelial cell line00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=758]], camposKey:0146-0404 2003-01-01 Characterization of a spontaneously immortalized cell line (IOBA-NHC) from normal human conjunctiva42634274, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53751]], camposKey:0960-0760 2003-01-01 Rat glomerulosa cells in primary culture and E. coli lipopolysaccharide action8188, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10415]], camposKey:0146-0404 2003-01-01 Uptake of bioadhesive nanoparticles in a normal human conjunctiva (NHC) epithelial cell line00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56665]], camposKey:0146-0404 2002-05-01 Immunodetection of muscarinic and adrenergic receptors in an epithelial cell line from human conjunctiva00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=762]], camposKey:0146-0404 2002-01-01 Characterization of an epithelial cell line derived from normal human conjunctiva (NHC cell line)00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=744]], camposKey:0146-0404 2002-01-01 Cyclosporin A does not alter the expression of ocular mucin genes in a normal human conjunctival (NHC) cell line00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53752]], camposKey:0730-2312 2000-01-01 Binding of Escherichia coli lipopolysaccharide to fasciculata-reticularis and glomerulosa cells evaluated by flow cytometry386394, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53753]], camposKey:0925-4439 1999-01-01 Calcium and reactive oxygen species as messengers in endotoxin action on adrenocortical cells110][][][][][][][][][][][][com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=31259]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=31022]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=30835]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=30320]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145638396]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145638267]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145636927]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145636938]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145637271]]][][][][][][][][com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@49b43d12, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@23c54099, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@6071cde2, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@305ad4bd, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@586e2309, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@51a66115][][com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3e6951, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@661ba7, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@661d62, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4d8828, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@662018, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@66210c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@662b7d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4d71eb, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@662c66, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@662865, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373bc5, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373bc2, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@37395c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@37326d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6629c1, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@662708, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6618d7, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@66206f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@661e78, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@661b82, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@661a90, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@662fe6][][][][][][][][com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c3119], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c469c], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c4718], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4617f6], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5ba283], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c46af], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412570], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c46cd], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c4696], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@411db1], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@411ead]][][][][][][][CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=30591]},camposKey: 29 42 Biomarcadores de ojo seco en estudios clínicos 9788412227215Lentes de contacto y superficie ocular: biomateriales 1 2020-01-01 Ulleye, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=30592]},camposKey: 43 54 Superficie ocular, lentes de contacto y condiciones ambientales 9788412227215Lentes de contacto y superficie ocular: biomateriales 1 2020-01-01 Ulleye]